Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
Recruiting · NCT06987916 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-06-05 | NCT06987916 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Tongji Hospital, Tongji University School of Medicine | 23 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Tongji Hospital ( Tongji Hospital of Tongji University) | Shanghai | China | 1 |